Common use of Safety Notices Clause in Contracts

Safety Notices. (A) there have been no recalls, field notifications, field corrections, market withdrawals or replacements, warnings, “dear doctor” letters, investigator notices, safety alerts or other notices of action relating to an alleged lack of safety, efficacy or regulatory compliance of the Company products (collectively, “Safety Notices”) that remain unresolved or open; and (B) to the Company’s knowledge, there are no material complaints with respect to the Company products that are currently unresolved. To the Company’s knowledge, there are no facts that would be reasonably likely to result in: (A) a material Safety Notice with respect to the Company products; (B) a material change in labeling of any of the Company products; or (C) a termination or suspension of marketing or testing of any of the Company products.

Appears in 3 contracts

Samples: Underwriting Agreement (Retrophin, Inc.), Underwriting Agreement (Travere Therapeutics, Inc.), Travere Therapeutics, Inc.

AutoNDA by SimpleDocs

Safety Notices. Except as would not reasonably be expected to have a Material Adverse Effect and except as otherwise disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (A) there have been are no recalls, field notifications, field corrections, market withdrawals or replacements, warnings, “dear doctor” letters, investigator notices, safety alerts or other notices notice of action relating to an alleged lack of safety, efficacy safety or regulatory compliance of the any Company products (collectively, “Safety Notices”) that remain unresolved or open; and (B) ), or, to the Company’s knowledge, there are no material product complaints with respect to the Company products that are currently unresolved. To Company’s products, and (B) to the Company’s knowledge, there are no facts that would be reasonably likely to result in: in (Ai) a material Safety Notice with respect to the Company Company’s products; (Bii) a material change in labeling of any of the Company Company’s products; or (Ciii) a termination or suspension of marketing or testing of any of the Company Company’s products.

Appears in 2 contracts

Samples: Blue Buffalo Pet Products, Inc., Blue Buffalo Pet Products, Inc.

AutoNDA by SimpleDocs

Safety Notices. (A) there There have been no material recalls, field notifications, field corrections, market withdrawals or replacements, warnings, “dear doctor” letters, investigator notices, safety alerts or other notices notice of action relating to an alleged lack of safety, efficacy efficacy, or regulatory compliance of the Company Company’s products (collectively, “Safety Notices”) that remain unresolved ), such Safety Notices, if any, were resolved or open; and (B) closed, and, to the Company’s knowledge, there are no material complaints with respect to the Company Company’s products that are currently unresolved. To the Company’s knowledge, there are no facts that would be reasonably likely to result in: in (Ai) a material Safety Notice with respect to the Company Company’s products; , (Bii) a material change in labeling of any of the Company Company’s products; , or (Ciii) a termination or suspension of marketing or testing of any of the Company Company’s products.

Appears in 1 contract

Samples: Orchestra BioMed Holdings, Inc.

Time is Money Join Law Insider Premium to draft better contracts faster.